Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$36.62 USD
-0.95 (-2.53%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $36.60 -0.02 (-0.05%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Vera Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -95.99 | -89.06 | -32.61 | -53.41 | -11.85 |
Depreciation/Amortization & Depletion | -4.09 | -0.85 | 0.18 | 0.25 | 0.51 |
Net Change from Assets/Liabilities | -5.87 | 6.75 | 3.51 | 0.12 | 0.52 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.76 | 15.56 | 5.21 | 18.23 | 0.54 |
Net Cash From Operating Activities | -92.18 | -67.60 | -23.71 | -34.81 | -10.29 |
Property & Equipment | -0.06 | -0.06 | -5.00 | -0.04 | -0.13 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -39.37 | -70.49 | 0.80 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -39.43 | -70.55 | -4.20 | -0.04 | -0.13 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 116.06 | 88.21 | 51.73 | 80.23 | 0.05 |
Issuance (Repayment) of Debt | 24.74 | 19.82 | 4.92 | 5.47 | -0.19 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.26 | -6.10 | -2.77 | -0.41 | 0.00 |
Net Cash from Financing Activities | 133.54 | 101.93 | 53.88 | 85.29 | -0.14 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.93 | -36.22 | 25.97 | 50.44 | -10.55 |
Cash at Beginning of Period | 43.75 | 79.97 | 54.00 | 3.56 | 14.11 |
Cash at End of Period | 45.68 | 43.75 | 79.97 | 54.00 | 3.56 |
Diluted Net EPS | -2.25 | -3.35 | -2.43 | -166.93 | NA |
Fiscal Year End for Vera Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -28.38 | -95.99 | -70.34 | -50.23 |
Depreciation/Amortization & Depletion | NA | -1.47 | -4.09 | -2.92 | -1.48 |
Net Change from Assets/Liabilities | NA | -8.62 | -5.87 | -3.79 | 1.12 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 4.64 | 13.76 | 10.01 | 6.52 |
Net Cash From Operating Activities | NA | -33.83 | -92.18 | -67.04 | -44.06 |
Property & Equipment | NA | 0.00 | -0.06 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -219.29 | -39.37 | -57.99 | -74.22 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -219.29 | -39.43 | -57.99 | -74.22 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 294.41 | 116.06 | 115.97 | 115.67 |
Issuance (Repayment) of Debt | NA | 0.00 | 24.74 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -17.87 | -7.26 | -7.26 | -7.26 |
Net Cash from Financing Activities | NA | 276.54 | 133.54 | 108.71 | 108.42 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 23.42 | 1.93 | -16.31 | -9.86 |
Cash at Beginning of Period | NA | 45.68 | 43.75 | 43.75 | 43.75 |
Cash at End of Period | NA | 69.11 | 45.68 | 27.44 | 33.89 |
Diluted Net EPS | NA | -0.56 | -0.54 | -0.45 | -0.46 |